STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3444 by analyst upside · 2026-08-13
BAX
Baxter International Inc.
Healthcare · Market Cap $14B · P/E 0x
ANALYST PRICE TARGET
+6.6%
implied upside to consensus target
Current Price $26.95
Consensus Target $28.73
Bull Target $40.0
Bear Target $23.0
Analysts Covering 11
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
1
Hold
9
Sell
0
52-Week Low $15.73
52-Week High $30.0
YTD Return +38.3%
FUNDAMENTALS
Market Cap $14B
P/E Ratio (TTM) N/A
Forward P/E 13.3x
EPS (TTM) $-1.88
PEG Ratio 36.68
Dividend Yield 14.00%
Revenue (TTM) $11.5B
Profit Margin -9.3%
52-WEEK RANGE
52-Week Low $15.73
52-Week High $30.0
Current Price $26.95
Bear Target $23.0
Bull Target $40.0
● Now $26.95 ● Target $28.73
TRADING DATA
Avg Volume 7.0M
YTD Return +38.3%
Analyst Count 11
Consensus Hold
Upside to Target +6.6%
Last Updated 2026-08-13

ANALYST SUMMARY

Baxter International Inc. (BAX) is currently trading at $26.95 with a Wall Street consensus price target of $28.73, implying potential upside of 6.6% over the next 12 months. 11 analysts currently cover BAX, with a consensus rating of Hold - 18% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $40.0, while the most cautious has a target of $23.0.

BAX operates in the Healthcare sector with a market capitalisation of $14B. The stock is up 38.3% year-to-date and is currently trading near the upper end of its 52-week range of $15.73 – $30.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for BAX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Citigroup ↓ Downgrade
Neutral → Sell 2026-05-28 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-05-04 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-04-06 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-03-11 Building track record
Goldman Sachs - Reiterated
Neutral → Neutral 2026-02-17 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-02-13 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-01-09 Building track record
Morgan Stanley - Reiterated
Underweight → Underweight 2025-12-02 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
38
out of 100
Coverage depth
19/30
Consensus clarity
17/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →